Spots Global Cancer Trial Database for Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls
Official Title: A Phase IV, Randomised Study to Evaluate the Immune Responses of UK Adolescent Girls Receiving CervarixTM or GardasilTM Human Papillomavirus Vaccines
Study ID: NCT00956553
Conditions
Study Description
Brief Summary: This is a phase IV study to evaluate the body's immune response of participants to the Cervarix and Gardasil vaccines against the Human Papilloma Virus (HPV) types associated with increased risk of cervical cancer.
Detailed Description: This study looks at possible cross reactivity between different HPV serotypes and both peripheral antibodies and mucosally-secreted antibodies.
Eligibility
Minimum Age: 13 Years
Eligible Ages: CHILD
Sex: FEMALE
Healthy Volunteers: Yes
Locations
Public Health England, Stevenage, Hertfordshire, United Kingdom
Professor Elizabeth Miller, Gloucester, , United Kingdom
Public Health England, London, , United Kingdom
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
